Todd Fehniger

Professor of Medicine, Division of Oncology, Sections of Stem Cell Biology and Bone Marrow Transplantation, WashU Medicine · Alvin J. Siteman Cancer Center

Credentials: · · · ·

History

Alvin J. Siteman Cancer Center
Present

Hematology and Medical Oncology
Washington University School of Medicine
2004–2007
Internal Medicine
Washington University School of Medicine
2002–2004
Ohio State University College of Medicine
1998–2002
Immunology, Ohio State University, Columbus, OH
2000

Research

The biology of human natural killer-cell subsets
Review · Trends in Immunology · 2001 · 2,378 citations
Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset
Blood · 2001 · 1,101 citations
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
European Journal of Immunology · 2019 · 843 citations

Amanda Cashen
35 papers
MC
Michael Caligiuri
32 papers
John DiPersio
29 papers
Megan Cooper
26 papers · 1 as a resident
Julia Wagner
22 papers · 9 as a resident
Rizwan Romee
22 papers · 2 as a fellow
Nancy Bartlett
21 papers
PW
Peter Westervelt
21 papers
David Russler-Germain
19 papers · 14 as a fellow
Camille Abboud
18 papers
Ravi Vij
18 papers
Geoffrey Uy
16 papers

Grants

Specialized Program of Research Excellence (SPORE) in Leukemia
National Cancer Institute · P50
Project lead · $2.9M · Washington University
2013–2029
Translating Nk Cell Biology into Clinical Cancer Immunotherapy
National Cancer Institute · R01
Contact PI · $2.4M · Washington University
2017–2022
Microrna Regulation of Nk Cell Development and Function
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.5M · Washington University
2013–2018
Molecular Mechanisms of Natural Killer Cell Cytokine-Activation
National Heart, Lung, and Blood Institute · K08
Contact PI · $582.5K · Washington University
2009–2014

Clinical trials

Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Principal investigator · Terminated · Phase 1
Washington University School of Medicine
2014–2018
Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma
Principal investigator · Completed · Phase 1
Washington University School of Medicine
2011–2021
Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma
Principal investigator · Completed · Phase 2
Washington University School of Medicine
2007–2016
Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia
Sub-investigator · Not yet recruiting · Phase 2
Washington University School of Medicine
2026–2032